Company
Synthomer PLC
LON:SYNT
Synthomer is a trusted partner of its customers around the world. We don’t sell chemicals – we sell formulations. Our innovative formulations and application know-how are an integral part of our customers’ products which cover a wide range of industries, including coatings, building products, gloves, carpets, paper, adhesives, plastics, PVC and many more.
44 stories · page 1 of 3
Archive
FTSE 100 Live: Stocks hold gains ahead of US tech results
The FTSE 100 has closed up 33.57 points at 7,666.31
Synthomer slumps as medical glove destocking continues post pandemic
Synthomer shares spiralled on Tuesday after the firm recorded a loss in 2022 and saw debt pile up
Synthomer sees in-line FY profit; nitrile latex demand subdued as pandemic eases
The company does not expects any pandemic premium from sales of nitrile latex in its results for the current year
Synthomer glues on £1bn US acquisition of Adhesive Technologies
The FTSE 250 company said the end markets are “attractive” and a strong innovation pipeline is expected to deliver “meaningful revenue growth” over the next few years
Synthomer upgraded to ‘overweight’ by JP Morgan over exposure to gloves market
Sales of nitrile latex for nitrile gloves for around 20% of 2019 group earnings
Synthomer surges as it upgrades earnings guidance, reinstates interim dividend
The polymer, sealant and chemicals specialist said as a result of strong third quarter trading it now expects its 2020 EBITDA to be around £232mln, 10% higher than previously forecast in August
Synthomer higher as it reinstates guidance and dividend plans
The polymer company said normalised trading had returned in June and continued into July
Synthomer rises as Deutsche Bank ups target price
The German bank's analysts said 2020 will be an "operational transition year" for the FTSE 250-listed firm
Synthomer shares drop as chemicals firm warns on profit, reviews portfolio
Full-year underlying profit before tax is likely to be 10% lower than 2018 mostly due to its styrene-butadiene rubber European business
Investments and investor services
Synthomer refutes allegations that its chairman is "over-boarded"
Synthonmer stood its ground over the reappointment of Neil "Three Chairs" Johnson but gave ground on calls for increased female representation on its board.
Archive
Synthomer stiffens up as UBS removes 'sell' recommendation
“We believe that the enlarged group can continue the shift towards more speciality products, rationalise production sites particularly in Europe and allow Synthomer to sell more products in the US”
Archive
Would you believe it, half the year is over?
Despite a lot of fear about, and problems across the world, markets don't seem to care.
Archive
Synthomer agrees to buy US polymers peer Omnova Solutions Inc for an enterprise value of US$824mln
The FTSE 250-listed UK firm is offering US$10.15 for each Omnova share, a premium of 58% to the NYSE-listed firm’s closing price on Tuesday
Peel Hunt likes industrials but wary of some 'nosebleed' valuations for Diploma and Spirax-Sarco
The flight to safety in 2019 has pushed the share price premium for a handful of UK industrial stocks to "nose-bleed multiples" not seen since the financial crisis, the broker said